ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,443Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 517

$669K Total Retail Price of All Prescriptions

Rank: 47 out of 517

519 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

11% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,907 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 484 436 1 1
METFORMIN HCL 412 337 2 4
OMEPRAZOLE 372 318 3 3
LISINOPRIL 331 290 4 7
AMLODIPINE BESYLATE 328 293 5 2
LEVOTHYROXINE SODIUM 279 195 6 6
LOSARTAN POTASSIUM 267 242 7 17
HYDROCODONE-ACETAMINOPHEN 239 145 S3 8 5
CARVEDILOL 230 214 9 26
PRAVASTATIN SODIUM 202 164 10 36
FUROSEMIDE 198 190 11 9
BENAZEPRIL HCL 190 176 12 15
DIOVAN 184 166 13 20
GLIMEPIRIDE 183 172 14 35
HYDROCHLOROTHIAZIDE 172 163 15 10
JANUVIA 155 134 16 43
GABAPENTIN 145 131 17 13
ATENOLOL 138 130 18 8
FLUTICASONE PROPIONATE 133 125 19 45
IBUPROFEN 105 94 20 16
FAMOTIDINE 104 90 21 44
TRIAMCINOLONE ACETONIDE 101 92 22 32
LOVASTATIN 99 99 23 23
VENLAFAXINE HCL ER 98 86 24 195
KETOCONAZOLE 97 77 25 139
TRAMADOL HCL 95 94 26 19
SPIRONOLACTONE 89 84 27 117
ATORVASTATIN CALCIUM 88 81 28 12
PANTOPRAZOLE SODIUM 87 81 29 38
TAMSULOSIN HCL 85 85 30 22
NORTRIPTYLINE HCL 84 66 31 180
AZITHROMYCIN 81 76 32 41
METOPROLOL SUCCINATE 81 77 32 21
POTASSIUM CHLORIDE 80 75 34 34
ZONISAMIDE 79 64 35 385
FLUCONAZOLE 78 48 36 351
ZOLPIDEM TARTRATE 78 56 36 14
CYMBALTA 78 56 36 71
BUPROPION XL 68 65 39 215
METOPROLOL TARTRATE 68 61 39 18
NAPROXEN 67 59 41 42
OLANZAPINE 63 36 42 111
DONEPEZIL HCL 63 63 42 28
ENALAPRIL MALEATE 62 62 44 39
ACETAMINOPHEN-CODEINE 61 46 S3 45 48
GLIPIZIDE 61 53 45 30
PREDNISONE 60 55 47 89
ALPRAZOLAM 60 50 47 225
METOCLOPRAMIDE HCL 59 54 49 119
COLCRYS 57 57 50 161
DIVALPROEX SODIUM 57 57 50 100
ALENDRONATE SODIUM 56 50 52 11
INSULIN SYRINGE 55 44 53 103
PAROXETINE HCL 54 48 54 76
WARFARIN SODIUM 53 53 55 24
METFORMIN HCL ER 53 29 55 163
CLOPIDOGREL 52 50 57 47
LACTULOSE 50 49 58 128
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.